PROKIDNEY CORP. 8-K

What Happened
On March 18, 2026, ProKidney Corp. (PROK) announced its financial results for the year ended December 31, 2025 by issuing a press release, which the company furnished as Exhibit 99.1 to a Form 8‑K (Item 2.02). The Form 8‑K was signed by Chief Financial Officer James Coulston. The company notes the press release is furnished (not “filed”) and therefore is not subject to Section 18 liability or automatically incorporated by reference into other filings.

Key Details

• Event: Furnished press release reporting ProKidney’s financial results for the year ended Dec. 31, 2025 (Form 8‑K, Item 2.02).
• Date: Press release and Form 8‑K dated March 18, 2026.
• Document: Press release included as Exhibit 99.1 to the Form 8‑K.
• Signature/Officer: Form 8‑K signed by James Coulston, Chief Financial Officer.

Why It Matters
This filing is the company’s public disclosure of its 2025 operating and financial performance; investors should review the furnished press release (Exhibit 99.1) for specific figures on revenue, earnings, and any management commentary or guidance. Because the release is “furnished” rather than “filed,” it has different legal treatment under the Exchange Act, and detailed, audited results may follow in periodic reports (e.g., Form 10‑K). If you own or follow PROK stock, check the press release and upcoming filings for the concrete numbers and company outlook.